Evestia Clinical (“the Company” or “the Group”) has merged with Atlantic Research Group (“ARG”), a US-based CRO, to create a leading independent global specialist CRO group in fast-growing markets. The merger expands Evestia Clinical’s global footprint in the US and broadens its therapeutic and services offering to include neurology and late-stage clinical trial services. The enlarged group also provides access to enhanced technologies to further meet the tailored needs of its clients. The deal immediately more than doubles the size of the Group by headcount and service delivery capability.
Read the full article: Evestia Clinical to Merge with Atlantic Research Group //
Source: https://www.globenewswire.com/news-release/2025/07/15/3115641/0/en/Evestia-Clinical-to-merge-with-Atlantic-Research-Group.html